Thailand signs procurement deal for 50,000 courses of Molnupiravir Covid pill

Thailand has signed a 500 million baht deal to buy 50,000 therapy programs of the new Covid-19 drug, Molnupiravir. According to a Thai PBS World report, the Medical Services Department signed the deal yesterday, with Health Minister Anutin Charnvirakul current to witness it. A course of remedy is made up of 40 x 200mg capsules. A affected person will want to take four capsules twice a day, 12 hours aside, for five days in a row.
The new treatment from pharmaceutical large Merck has proven promising results in trials and Anutin says it will be given to Covid-19 patients with moderate to extreme symptoms, as well as sufferers considered high-risk. Dr. Somsak Akksilp from the Medical Services Department says the producers have applied for emergency use approval from both the US Food and Drug Administration and the Thai FDA.
Molnupiravir works by interacting with the genetic code of Covid-19, introducing errors that hinder the effects of the virus. Thai PBS World reviews that it first came about when research at Emory University in the US discovered that a molecule generally identified as NHC/EIDD-2801 had efficiency in opposition to varied coronaviruses. The molecule was subsequently licenced to biotechnology agency Ridgeback Biotherapeutics, who partnered with Merck to develop the drug.
Subsequent trials showed that it could halve the chance of hospitalisation with Covid-19. Earlier this month, the UK turned the first nation on the planet to approve the drug, with the US FDA anticipated to comply with swimsuit subsequent month.
For Simple as ABC on Covid-19 Insurance, CLICK HERE.
SOURCE: Thai PBS World

Leave a Comment